Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
04 June 2024 | Story Leonie Bolleurs | Photo Kaleidoscope Studios
Prof Hendrik Swart
Prof Hendrik Swart’s prolific publication record, the high impact of his work, and the outstanding quality of his scholarly contributions have placed him among the top 0,05% of all scholars worldwide.

ScholarGPS awarded Prof Hendrik Swart, Senior Professor in the Department of Physics at the University of the Free State (UFS), Highly Ranked Scholar status.

ScholarGPS celebrates Highly Ranked Scholars™ for their performance in various fields, disciplines, and specialties. Prof Swart’s prolific publication record, the high impact of his work, and the outstanding quality of his scholarly contributions have placed him among the top 0,05% of all scholars worldwide.

Prof Swart received Highly Ranked Scholar status (Lifetime) for ranking 16th in the discipline of Phosphor. Highly Ranked Scholars™ – Lifetime refers to distinguished authors, including those who are currently active, retired, or deceased. These scholars are recognised for their exceptional lifetime scholarly contributions, placing them in the top 0,05% of all scholars. Their achievements are evaluated across four categories: overall (across all fields), within their specific field of study, within their particular discipline, and across all specialties they are associated with.

Additionally, Prof Swart received Highly Ranked Scholar status (prior five years) for ranking first in Condensed Matter Physics, 42nd in Physics, 155th in Sensor, 207th in Physical Science and Mathematics, and 969th in all fields.

Scientific profile and credibility

ScholarGPS is a California-based company that applies artificial intelligence, data mining, machine learning, and other data science techniques to its massive database of more than 200 million publications and 3 billion citations to rank more than 30 million scholars and 55 000 institutions worldwide. They categorise more than 200 million scholarly publications into specific academic specialties. These specialties are further organised into 177 disciplines and 14 overarching fields. As a result of this extensive classification effort, scholars who are considered highly ranked within their respective fields can now be identified with greater precision. This identification is done not only within each academic specialty, but also across disciplines and fields, providing a comprehensive view of scholarly achievement and expertise. This system allows for the identification of top scholars within various areas of academic research in a way that was not possible before.

Prof Swart, who is an NRF B1-rated researcher, currently also holds the SARChI Research Chair: Solid-state Luminescent and Advanced Materials (2023-2027). On receiving this award from ScholarGPS, he says it is always a privilege to be recognised as one of the top scholars in your specific field, especially at this late stage of his career.

Professionally, Prof Swart says this award may boost his scientific profile and credibility in the academic community, potentially leading to more collaborations and partnerships.

In the field of condensed matter physics, the impact of his work is specifically noteworthy in the study of defects and impurities within semiconductors, along with their practical applications in optoelectronic devices. Moreover, his significant contributions extend to understanding optical and electronic properties at the nanoscale, bearing implications for the development of semiconductor technology, including light-emitting diodes (LEDs), photovoltaic cells, and quantum dots.

Primarily focused on mentorship

He believes his successes in physics and advances in understanding the universe are the result of a combination of variables, including innovative research, collaboration and networking, mentorship, effective communication, persistence, and resilience. “I am primarily focused on mentorship, which is critical to developing the next generation of physicists and creating a supportive environment for learning and discovery, as well as conducting groundbreaking research and making novel discoveries that are critical to pushing the boundaries of physics. I am always searching for opportunities to collaborate with other scholars, both inside and outside my discipline, which will result in constructive exchange of ideas, interdisciplinary discoveries, and collective problem solving.”

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept